Sanofi Invest Information

Pharmaceuticals
Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU Sep 21, 2024
Pharmaceuticals
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents Sep 14, 2024
Pharmaceuticals
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment Jul 4, 2024
Pharmaceuticals
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP May 14, 2024